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KEY FINDINGS 
 
In every year studied, the non-CDHP 
population had total per capita spend-
ing higher than the CDHP population. 
 
The CDHP population had  rates of 
utilization 9%-13% lower than the non
-CDHP population for all categories of 
health services outside of brand pre-
scriptions, which was 21% lower.  
 
The CDHP population spent an aver-
age annual $343 per capita more out 
of pocket than did the non-CDHP pop-
ulation.  
 
The non-CDHP population was respon-
sible for an average of 14% of their 
medical costs out of pocket, whereas 
the CDHP population paid for 24% of 
their medical costs.  
Consumer-Driven Health 
Plans: A Cost and Utilization 
Analysis 
A consumer-driven health plan (CDHP), 
also known as a consumer-directed 
health plan, is a health insurance plan 
design increasingly prevalent in the 
United States.1 CDHPs are a specific 
type of high-deductible health plan gen-
erally including a health savings ac-
count (HSA) or a health reimbursement 
arrangement (HRA).2 Compared to tra-
ditional commercial health plans—such 
as a health maintenance organization 
(HMO), preferred provider organization 
(PPO), or point of service (POS) plan 
type—CDHPs typically have lower pre-
mium rates in exchange for higher mini-
mum deductibles and higher maximum 
out-of-pocket limits.3 Though benefit 
designs vary from plan to plan, these 
higher minimum deductibles generally 
require more consumer dollars to be 
spent out of pocket before the insurer 
begins to pay a portion of the costs. 
When deductibles are met, cost sharing 
between the insurer and consumer 
begins, and the insurer becomes re-
sponsible for a larger percentage of the 
consumer’s incurred medical expenses. 
Thus, higher minimum deductibles gen-
erally lead to higher consumer yearly 
maximum out-of-pocket burdens. 
Through these higher minimum de-
ductibles, CDHPs attempt to alter their 
consumers’ behavior by placing greater 
monetary responsibility on consumers 
in the hopes of reducing the use of un-
necessary care and spending. 4  
CDHP enrollment has been increasing 
steadily within HCCI’s employer-
sponsored insurance (ESI) population 
since 2010 (see Membership by plan 
type in the HCCI study population). Ac-
cording to the Kaiser Health Benefits 
survey, 13% of covered workers were 
enrolled in some sort of high-deductible 
health plan in 2010. By 2014, that num-
ber had risen to 20% of covered work-
ers, an increase of more than 50%.1 This 
growing prevalence highlights the im-
portance of better understanding the 
trends in spending and utilization for 
CDHP consumers, and how they com-
pare to their non-CDHP counterparts.  
This issue brief examined the total 
spending, utilization, and out-of-pocket 
spending trends for individuals who are 
covered by ESI and younger than 65 
years, with CDHPs and with non-CDHPs, 
between the years 2010 and 2014 (the 
“study period”). Consumers were iden-
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tified by their insurer as being covered by 
a CDHP and then separated into two pop-
ulations: the non-CDHP population and 
the CDHP population (see Data and Meth-
ods). Spending trends for these popula-
tions do not include information on pre-
mium payments, and this issue brief does 
not examine the potential impacts of pre-
miums on health care trends. By examin-
ing the non-CHDP and CDHP populations 
side by side, we highlighted the similari-
ties and differences in the spending and 
utilization trends for the two populations. 
Study limitations 
This issue brief presents cost and utilization trends for the national ESI population younger than age 65 covered by either CDHP 
or non-CDHP insurance design. This work should be viewed as a starting point in the examination of these trends. There are 
many factors that influence how and where people seek health care and how much they pay for it. HCCI does not have data on 
premiums, the range of insurance options offered by employers, the actual benefit design of plans, or employer contributions 
to any Health Saving Account (HSA) or Health Reimbursement Account (HRA). Additionally, there are likely selection effects that 
influence the choice of insurance plan (where one exists) and how an individual uses their plan. We also did not risk adjust to 
account for potential population differences. These omitted factors likely have an important impact. Future research should 
consider how these factors influence cost and utilization trends of the privately insured.  
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Per capita spending lower in CDHP 
population 
Over the study period, spending per capi-
ta (total expenditure divided by the num-
ber of individuals covered by the plan 
type) for the non-CDHP population was 
higher than that for the CDHP population 
(Figure 1). Beginning with the initial study 
year of 2010, the difference in per capita 
spending between the two populations 
increased every year. In 2014, per capita 
spending for the non-CDHP population 
was $659 greater than that for the CDHP 
population: $5,140 and $4,481, respec-
tively (Table 1). Over the study period, 
the CHDP population had per capita 
spending lower than that of the non-
CDHP population across all categories of 
health services and nearly all demograph-
ic groups. This section compared differ-
ences in per capita spending between the 
two populations for various demographic 
groups and categories of health services.  
For both men and women in the non-
CDHP population, spending per capita 
was higher as compared to the spending 
per capita for the CDHP population. With-
in each population, women had higher 
spending than did men. Interestingly, 
both female populations spent roughly 
the same percentage more than did their 
respective male counterparts. On aver-
age, across all 5 years, per capita spend-
ing for women covered by CDHPs was 
1.25 times greater than that for men hav-
ing a CDHP (Table 1). For non-CDHP con-
sumers over the same time frame, spend-
ing per capita for women was, on aver-
age, 1.28 times higher than that for men. 
These similar proportions suggest that 
plan type played only a small role in 
spending differences by gender (see Plan 
type may not impact one gender more 
than the other for additional discussion).  
As seen in Exhibit 1, the three oldest age 
groups (ages 26–44, 45–54, and 55–64) 
displayed ratios similar to the national 
benchmark, whereas the spending ratios 
for the youngest age groups (ages 18 and 
younger; ages 19–25) were lower than 
the national benchmark. This suggests 
that per capita spending differences be-
tween plan types were larger for the old-
er age groups than for the youngest.  
For the group ages 18 and younger, the 5
-year average spending ratio was 1.06. 
Even more striking, for ages 19 to 25, the 
average spending ratio was less than 
1.00. The average per capita spending 
rate was slightly higher in the CDHP pop-
ulation than in the non-CDHP population 
for 19 to 25-year-olds, the only age group 
in which that trend was observed (for 
additional discussion see, Ages 19–25 
Was an Outlier Group).  
Beyond demographics, we examined the 
differences in the per capita dollars spent 
on categories of health services for the 
two populations. We divided health care 
services into four service categories: in-
patient admissions, outpatient services, 
professional services, and prescriptions. 
These service categories were divided 
into subservice categories, which in turn 
were composed of detailed service cate-
gories.5  
When examining the per capita spending 
differences by service category, the larg-
est differences in spending between the 
two populations were for prescriptions. 
Over the study period, the non-CDHP 
population had average annual spending 
on prescriptions $190 greater than that 
of the CDHP population (Table 2). In eve-
Exhibit 1. Average Per Capita 
Spending Ratio, by Age (2010 - 
2014) 
Age Group 
Per Capita 
Spending Ratio  
Total Study Population  1.12 
Ages 18 and Younger 1.06 
Ages 19-25 0.99 
Ages 26-44 1.12 
Ages 45-54 1.13 
Ages 55-64 1.11 
Source: HCCI, 2016. Note: Spend ratio is calculated 
as the  5-year non-CDHP per capita spend average 
divided by the 5-year CDHP per capita spend aver-
age, Table 1.   
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Notes: All data weighted to reflect the national, younger than 65 ESI population.
Data from 2013 and 2014 adjusted using actuarial completion.
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of Cost, by Plan Type
Figure 1
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ry year since 2012, the difference in per 
capita spending on prescriptions between 
the two populations widened. The largest 
difference was in 2014, when the per 
capita spending on prescriptions for the 
non-CDHP population was $959, as com-
pared to $715 per capita for the CDHP 
population (a difference of $244 dollars). 
Prescriptions also had the largest relative 
per capita spending difference of any 
service category between the two popu-
lations. On average, across the 5-year 
study period, the non-CDHP population 
had per capita spending on prescriptions 
that was 28% higher than that for the 
CDHP population. For comparison, spend-
ing per capita by the non-CDHP popula-
tion was 9% greater, on average, than 
that of the CDHP population for the other 
three categories of services combined.  
In 2014, the $244 difference between the 
two populations in per capita spending 
on prescriptions was largely due to 
spending on brand prescriptions (Table 
2). The non-CDHP population had spend-
ing per capita on brand prescriptions that 
was $164 higher than that for the CDHP 
population. In comparison, spending per 
capita on generic prescriptions for the 
non-CDHP group was $79 higher than 
spending for the CDHP population. In 
terms of dollars, the difference between 
the non-CDHP and CDHP per capita 
spending was more than twice as large 
on brand prescriptions as on generic pre-
scriptions in 2014. Compared to this large 
difference in dollars spent on brand ver-
sus generic prescriptions, the relative 
difference between the populations in 
per capita spending on these two types 
of prescriptions was much smaller. 
Spending per capita for the non-CDHP 
population on brand prescriptions was 
35% higher than that for the CDHP popu-
Membership by plan type in the HCCI study population 
In every year studied, the percentage of the HCCI population covered by a CDHP increased. In 2010, the CDHP population made 
up 15% of the ESI population younger than 65 (Table 11 and Figure 2). By 2014, that number increased to 27% of the ESI popu-
lation. The percentage of the CDHP population that was male versus female was relatively similar, and these proportions 
changed little over the study period. In 2014, the age group with the largest percentage covered by a CDHP was ages 18 and 
younger (29% of the age group), whereas the group ages 55 to 64 had the smallest percentage enrolled in a CDHP (24% of the 
age group). For every age group, the percentage of those covered by a CDHP increased in each year studied. 
In every year studied, the percentage of 
the HCCI population covered by a CDHP 
increased. In 2010, the CDHP population 
made up 15% of the ESI population young-
er than 65 (Table 11 and Figure 2). By 
2014, that number increased to 27% of 
the ESI population. The percentage of the 
CDHP population that was male versus 
female was relatively similar, and these 
proportions changed little over the study 
period. In 2014, the age group with the 
largest percentage covered by a CDHP 
was ages 18 and younger (29% of the age 
group), whereas the group ages 55 to 64 
had the smallest percentage enrolled in a 
CDHP (24% of the age group). For every 
age group, the percentage of those cov-
ered by a CDHP increased in each year 
studied.  
The number of non-utilizers (consumers 
who had a health insurance plan but did 
not file a claim in a given year) was also 
examined. A larger percentage of the non-CDHP population did not have a claim, as compared to the CDHP population. In 2014, 
28% of the total non-CDHP population did not file a claim, as compared to 25% of the total CDHP population (Table 12). This 
difference was largest for the 19- to 25-year group. In 2014, 38% of the CDHP 19- to 25-year-old population did not file a claim, 
and 46% of the non-CDHP 19- to 25-year-olds did not.  
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lation. For generic prescriptions, the non-
CDHP population had per capita spending 
that was 32% higher than that for the 
CDHP population.  
Across the four service categories, the 
second largest difference in average per 
capita spending was on inpatient admis-
sions. The non-CDHP population had an-
nual average per capita spending that 
was 15% higher than such spending for 
the CDHP population (Table 2). In 2014, 
spending per capita on inpatient admis-
sions for the non-CDHP population was 
$139 more than for their CDHP counter-
parts. The difference in per capita spend-
ing between the populations was driven 
largely by the spending differences on 
inpatient surgical admissions and inpa-
tient medical admissions. Of the $139 
spending difference, $69 resulted from 
the difference in spending for surgical 
admissions, and $49 came from inpatient 
medical admissions (Table 3). Surgical 
admissions also had the highest per capi-
ta spending of any detailed service cate-
gory for both populations. In 2014, per 
capita spending on surgical admissions 
was $526 for the non-CDHP population 
and $457 for the CDHP population.  
Utilization rates lower in CDHP 
population 
As mentioned above, CDHPs are designed 
to lower health care expenditures by 
moderating utilization. These plans use 
minimum deductibles that are higher 
than traditional health plans, which can 
raise consumers’ cost of utilizing ser-
vices.4 Theoretically, the effect of the 
higher deductible limit is to minimize 
both the use of and spending on unnec-
essary health services. This section exam-
ined the utilization trends of categories of 
health services by our CDHP study popu-
lation and compared them to those of 
the non-CDHP study population. 
For every service and subservice catego-
ry, across all the years studied, the popu-
lation of consumers covered by a CDHP 
had utilization rates lower than those of 
the non-CDHP population. As with per 
capita spending above, examining only 
the simple differences between the two 
populations’ utilization rates could result 
in incomplete conclusions. For a clearer 
description of the utilization differences 
between populations, we examined the 
‘utilization ratio’ between the CDHP and 
the non-CDHP populations. The utiliza-
tion ratio was created by dividing the 5-
Source: HCCI, 2016 
Notes: Data represents the weighted population of insureds 0-64 covered by ESI, for the year 2011  
Ages 19–25 was an outlier group 
Of the 5 age groups, the group ages 19 to 25 was the only age group studied that had higher per capita spending for the CDHP 
population than for the non-CDHP population. Across the 5-year study period, spending for the 19- to 25-year-olds was an aver-
age annual 1% ($26) higher for the CDHP population (Table 1). Similarly, out-of-pocket per capita spending for this age group 
was also higher for the CDHP population. The CDHP population spent 81% more out of pocket per capita, as compared to the 
non-CDHP population (Table 9). This was the largest difference in out-of-pocket spending between the two populations ob-
served for any age group. The ages 19 to 25 
CDHP population also bore the highest share of 
cost of any of the age groups studied. Over the 
5 years studied, the CDHP population at ages 19 
to 25 paid an average of 30% of their medical 
costs out of pocket, as compared to just 17% 
for the non-CDHP 19- to 25-year-olds (Tables 1 
and 9). 
Additionally, among all age groups studied, the 
group ages 19 to 25 had the lowest non-CDHP-
to-CDHP ‘utilization ratio’ across every service 
category (see Exhibit 2). The CDHP population, 
on average, used more outpatient and profes-
sional services than did the non-CDHP popula-
tion, while having similar rates of filled days of 
prescriptions (Tables 6 and 7). Examination of 
this age group’s utilization ratios by gender 
revealed that the male non-CDHP and CDHP 
utilization rates were generally similar (ratios slightly more than 1.00; see Exhibit 2). However, the female ratios for the majority 
of services were less than 1.00, suggesting a higher rate of use for the women who had a CDHP. In three of the four service cat-
egories, the female ratio was less than or equal to 0.97, with the lowest ratio (0.94) occurring in outpatient services.  
Exhibit 2. Average Non-CDHP to CDHP Utilization Ratio, by 
Age and Service Category (2010 - 2014) 
Age Group 
Inpatient 
Admissions 
Outpatient 
Services 
Professional 
Services Prescriptions 
Total Study Population 1.15 1.11 1.11 1.15 
Ages 18 and Younger 1.09 1.07 1.05 1.09 
Ages 19-25 1.03 0.97 0.99 1.00 
     19-25 Men 1.07 1.01 1.02 1.04 
     19-25 Women 1.03 0.94 0.97 0.97 
Ages 26-44 1.13 1.07 1.13 1.14 
Ages 45-54 1.20 1.09 1.11 1.16 
Ages 55-64 1.17 1.11 1.11 1.17 
Source: HCCI, 2016. Note: Utilization ratio is calculated as the 5-year non-CDHP utilization 
average divided by the 5-year CDHP utilization average, Tables 6 and 7. 
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year average CDHP utilization rate by the 
5-year average non-CDHP utilization rate 
for each service and subservice category. 
Given that the CHDP population had low-
er utilization across all services as com-
pared to the non-CDHP population, every 
utilization ratio was less than 1.00. There-
fore, a high ratio—close to 1.00—would 
indicate that the CHDP population had a 
utilization rate similar to that of the non-
CDHP population. A lower ratio, farther 
from 1.00, suggests a larger difference in 
the two populations’ utilization rates. For 
example, the utilization ratio for inpatient 
admissions was calculated as the study 
period’s average CDHP inpatient admis-
sions utilization rate (52 admissions per 
1,000 individuals) divided by the average 
non-CDHP rate (60 admissions per 1,000 
individuals; Table 4). The ratio (0.87) indi-
cates that the CDHP population, on aver-
age, used 13% fewer inpatient admissions 
than did the non-CDHP population each 
year.  
As seen in Exhibit 3, the differences in 
utilization between the two populations 
were fairly consistent across service cate-
gories. Outside of brand prescriptions, 
average utilization rates of the CDHP pop-
ulation were 9% to 13% lower (utilization 
ratio range of 0.87–0.91) than the rates of 
the non-CDHP population for every other 
service and subservice category.  
Only brand prescriptions (a ratio of 0.79) 
had a considerably lower utilization ratio 
(Exhibit 3). The CDHP population used an 
average annual 21% fewer filled days per 
1,000 individuals of brand prescriptions 
than did the non-CDHP population. Brand 
prescriptions had the lowest utilization 
ratio (i.e., the largest difference in utiliza-
tion between the two populations), 
whereas generic prescriptions had a ratio 
(0.89) similar to that of the medical ser-
vice categories.  
We also observed low utilization ratios 
(compared to the 0.87–0.91 range for 
medical service categories) within the 
detailed categories of brand prescrip-
tions. Every brand prescription detailed 
category had a utilization ratio lower than 
0.87, the minimum value in the utilization 
ratio range. The detailed category of 
brand prescriptions with the largest utili-
zation ratio (the smallest difference in 
average annual use between the two 
populations) was brand respiratory drugs 
(0.84; Table 5). The CDHP population uti-
lized 16% fewer filled days of brand res-
piratory drugs than did the non-CDHP 
Plan type may not Impact one gender more than the other 
As discussed in previous HCCI reports, per capita spending, out-of-pocket spending per capita, and service utilization rates tend-
ed to be higher for women than for men.6 As CDHPs are designed to affect both spending and utilization, we compared the 
trends for men and women to look for differences by plan type. When the ‘gender ratios’ (5-year average female rate divided 
by the 5-year average male rate) were compared between the two populations, there were small differences in per capita 
spending, out-of-pocket spending, and utilization. 
Over the 5-year study period, the non-CDHP per capita spending gender ratio was 1.25, whereas the CDHP gender ratio was 
1.28 (Table 1). The difference between the populations’ gender ratios was even smaller for out-of-pocket spending. The non-
CDHP per capita out-of-pocket spending gender ratio was 1.34, as compared to 1.36 for the CDHP population (Table 9). Com-
pared to the spending gender ratios, there were slightly larger differences between the two populations’ utilization gender rati-
os for some service categories. Among the four service categories, inpatient admissions had the largest difference between the 
utilization gender ratios: 1.60 and 1.53 for the CDHP and non-CDHP populations, respectively (Table 8). Professional services 
had the smallest utilization gender ratio difference. The CDHP population had a utilization gender ratio of 1.47, as compared to 
1.45 for the non-CDHP population. Overall, little evidence suggested differential spending and use trends between genders by 
plan type.  
Exhibit 3. Average CDHP to Non-CDHP Utilization Ratio, by Service 
and Subservice Category (2010 - 2014) 
Service Category 
Non-CDHP 
Population 
CDHP      
Population 
Utilization Ratio 
(CDHP/Non-CDHP) 
Inpatient 60 52 0.87 
     Acute Inpatient 57 50 0.88 
Outpatient 2,953 2,664 0.90 
     Outpatient Visits 327 297 0.91 
     Outpatient-Other 2,626 2,368 0.90 
Professional Services 16,580 14,972 0.90 
Prescriptions - Filled Days 287,100 249,559 0.87 
     Brands 60,243 47,383 0.79 
     Generics 226,810 202,159 0.89 
Source: HCCI, 2016. Note: Utilization ratio is calculated as the 5-year non-CDHP utilization average divided 
by the 5-year CDHP utilization average, Table 4. 
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population each year on average. The 
smallest utilization ratio (0.66; the largest 
difference in average annual use between 
the two populations) was brand gastroin-
testinal drugs. The CDHP population filled, 
on average, 34% fewer filled days of 
brand gastrointestinal drugs each year, as 
compared to those for the non-CDHP 
population. 
In general, over the study period, there 
were declines in the rates of utilization of 
services for both populations. In each 
year studied, for the two populations, 
utilization of inpatient admissions, outpa-
tient services, and filled days of brand 
prescriptions declined (Table 4). In the 
final study year (2014), utilization rates of 
professional services for both populations 
were higher than in the initial study year 
(2010). However, utilization of profession-
al services by the CDHP population de-
clined from 2012 onward, and from 2013 
onward for the non-CDHP population. In 
contrast, in every year studied, both pop-
ulations had increasing rates of utilization 
of filled days of generic prescriptions.  
Across the service and subservice catego-
ries, the changes in utilization rates dur-
ing the study period differed in both di-
rection and magnitude. To analyze the 
changes in utilization of service catego-
ries, the ‘change in utilization ratio’ was 
calculated for the non-CDHP and CDHP 
populations (Exhibit 4). For each service 
and subservice category, by plan type, the 
2014 utilization rate was divided by the 
2010 utilization rate. The changes in utili-
zation differed widely by service and sub-
service category (Exhibit 4). For example, 
for the CDHP population, there was an 
11% decrease in inpatient admissions and 
a 2% increase in outpatient visits.  
Of all the service and subservice catego-
ries, brand and generic prescriptions had 
the largest percentage changes in their 
utilization rates. Over the study period, 
utilization of filled days of brand prescrip-
tions decreased by 48% for the non-CDHP 
population and by 53% for the CDHP pop-
ulation. In contrast, use of filled days of 
generic prescriptions increased by ap-
proximately 25% for both populations.  
The changes in utilization between 2010 
and 2014 for each of the categories of 
services were relatively similar for the 
CDHP population, as compared to the non
-CDHP population. For each service cate-
gory, the two populations’ change in utili-
zation ratios were compared to examine 
the similarities between their utilization 
trends. For all medical service and sub-
service categories and generic prescrip-
tions, the difference between the non-
CDHP change in utilization ratio and the 
CDHP change in utilization ratio was less 
than 2% (Exhibit 4). For brand prescrip-
tions, the difference between the change 
in utilization ratios was slightly higher, a 
difference of 5%. Over the study period, 
these observed changes in the utilization 
of each health service category have been 
in the same direction and at similar rates 
of change for both populations.  
Out-of-Pocket spending substan-
tially higher in the CDHP popula-
tion  
The principal feature of CDHPs is higher 
minimum deductibles, which may lead to 
consumer out-of-pocket expenditures 
greater than those typically faced by con-
sumers with non-CDHPs. However, it is 
also possible that the lower utilization 
rates for the CDHP population (discussed 
above) may lead to correspondingly lower 
out-of-pocket expenses. In this section, 
we compared the out-of-pocket per capi-
ta spending rates for both populations, 
finding higher per capita out-of-pocket 
spending by the CDHP population, as 
compared to that of the non-CDHP popu-
lation (Figure 1).  
The non-CDHP population had total per 
capita spending higher than that of the 
CDHP population across all categories of 
health services and almost all de-
mographics groups. For consumer per 
capita out-of-pocket spending, the oppo-
site trend was observed, with the CDHP 
population having out-of-pocket spending 
rates consistently higher than those of 
the non-CDHP population. Over the 5-
year study period, the population covered 
by a CDHP spent an average annual $343 
per capita more out of pocket than did 
the non-CDHP population (Table 9 and 
Figure 1). Between 2012 and 2014, aver-
age per capita out-of-pocket spending for 
the CDHP population was more than 1.5 
Exhibit 4. 2010 to 2014 Change in Utilization, by Service and Sub-
service Categories 
Service Category Non-CDHP CDHP 
Inpatient -11% -11% 
   Acute Inpatient -8% -9% 
Outpatient -1% -1% 
   Outpatient Visits 1% 2% 
   Outpatient-Other -1% -1% 
Professional Services 3% 1% 
Prescriptions - Filled Days 3% 4% 
   Brands -48% -53% 
   Generics 23% 25% 
Source: HCCI, 2016. Note: The change in utilization was calculated by dividing the 2014 utilization rate by 
the 2010 utilization rate, for each population, Table 4. 
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times greater than such spending for 
their non-CDHP counterparts. For exam-
ple, in 2014, the CHDP population’s per 
capita out-of-pocket spending was 
$1,083, as compared to $709 for the non-
CDHP population.  
This relationship between the two popu-
lations’ per capita out-of-pocket spend-
ing was also observed when considering 
gender and age groups. In every year 
examined, the CDHP population, for both 
genders and all 5 age groups, had per 
capita out-of-pocket spending higher 
than that of the corresponding non-CDHP 
population. Similar to the total per capita 
spending comparisons between genders, 
women spent more per capita out of 
pocket than did men. Also as with total 
per capita spending, both the non-CHDP 
and the CDHP female populations’ per 
capita out-of-pocket costs were roughly 
the same percentage greater than that of 
their respective male counterparts. The 
5-year average female-to-male ‘out-of-
pocket spending ratio’ (the average fe-
male out-of-pocket spending rate divided 
by the average male out-of-pocket 
spending rate) for the CDHP population 
was 1.36; for the non-CDHP population it 
was 1.34 (Table 9). We did not find that 
the type of health plan substantially im-
pacted the out-of-pocket spending trends 
of one gender more than the other.  
The CDHP population had higher out-of-
pocket spending than did the non-CDHP 
population for every age group in every 
year. To better understand the differ-
ences across age groups in spending be-
tween plan types, we calculated the 5 
age groups’ ‘out-of-pocket spending rati-
os’ (5-year average CDHP out-of-pocket 
spending rate divided by the 5-year aver-
age non-CDHP out-of-pocket spending 
rate, for each age group) and compared 
them to the total ESI population out-of-
pocket benchmark ratio. Across the study 
period, the out-of-pocket spending ratio 
for the total study population was 1.50: 
average annual out-of-pocket spending 
of $1,030 for the CDHP population and 
$687 for the non-CDHP population (Table 
9). Out-of-pocket spending for the two 
populations became more similar to each 
other with increased age. Of the three 
oldest age groups, only 26- to 44-year-
olds had an out-of-pocket ratio (1.57) 
greater than the national benchmark. 
The two oldest age groups had out-of-
pocket ratios of 1.43 and 1.38, respec-
tively.  
The two youngest age groups (younger 
than 18 and 19–25) had out-of-pocket 
spending ratios considerably higher than 
the national benchmark ratio. For the 
youngest age group (ages 0–18), the out-
of-pocket spending ratio was 1.68 (Table 
9). The out-of-pocket spending ratio for 
the 19- to 25-age group was 1.81, the 
largest ratio of any age group. These rati-
os indicate that the CDHP population in 
these two age groups spent a yearly aver-
age of 68% and 81%, respectively, more 
out of pocket per capita than did their 
non-CDHP counterparts (see Ages 19–25 
was an Outlier Group).  
Per capita out-of-pocket spending for the 
CDHP population was greater than the 
out-of-pocket spending for the non-CDHP 
population for every service and sub-
service category. Over the study period, 
the largest differences in per capita out-
of-pocket spending between the two 
populations were for professional ser-
vices ($185 difference on average) and 
outpatient services ($114; Table 10). 
These two categories also had the high-
est out-of-pocket spending of any service 
category for both populations. On aver-
age, across the 5-year study period, per 
capita out-of-pocket spending on profes-
sional services amounted to $294 for the 
non-CDHP population and $479 for the 
CDHP population. For outpatient ser-
vices, per capita out-of-pocket spending 
was $172 and $286 for the non-CDHP 
and CDHP populations, respectively.  
Among the detailed service categories, 
doctor’s visits had the highest per capita 
out-of-pocket spending for both popula-
tions and the largest out-of-pocket 
spending difference between the popula-
tions. Over the study period, the CDHP 
population spent, on average, $58 more 
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out of pocket per capita on visits to the 
doctor than did their non-CDHP counter-
parts (Table 10). The emergency room 
(ER) visits detailed category had the sec-
ond largest difference in average per 
capita out-of-pocket spending between 
the CDHP and non-CDHP populations: a 
difference of $50 more for the CDHP pop-
ulation per year, on average. In contrast 
to the higher out-of-pocket per capita 
spending, over the study period, the 
CDHP population annually had a lower 
utilization rate of ER visits and doctor’s 
visits than that of the non-CDHP popula-
tion (Table 4). On average, the CDHP 
population had 10% fewer ER visits, 
whereas they spent 2.21 times more per 
capita out-of-pocket than did their non-
CDHP counterparts (Figure 2). For doc-
tor’s visits, the CDHP population utilized, 
on average, 8% fewer visits than did the 
non-CDHP population but spent 1.63 
times more out of pocket per capita 
(Figure 3).  
Generally, the CDHP population had high-
er out-of-pocket spending and lower to-
tal per capita spending than did the non-
CDHP population. This led to considera-
ble differences between the populations 
when the “share of cost” was examined. 
Share of cost was measured as the pro-
portional amount of the spending per 
capita on health services that individual 
consumers paid out of pocket. Share of 
cost was calculated as per capita out-of-
pocket spending divided by per capita 
total spending. As shown in Exhibit 5, the 
share of cost for the non-CDHP popula-
tion averaged 14% per year across the 
study period. The CDHP population, how-
ever, was responsible for an average of 
24% of their total per capita costs (Figure 
1).  
Examining by service categories revealed 
that the share of costs borne by the 
CDHP population on professional services 
and prescriptions was more than 30% of 
the total per capita spending on those 
services per year, on average (Exhibit 5). 
Professional services had the highest 
share of cost for the CDHP population 
(32% on average). In contrast, for the 
non-CDHP population, the largest share 
of cost was for prescriptions (20% on 
average). The share of costs for both 
populations was lowest on inpatient ad-
missions. The CDHP population paid 6% 
of the per capita inpatient spending out 
of pocket, compared to 5% for the non-
CDHP population. Overall, on all the ser-
vice categories, the CDHP population had 
a share of cost higher than that of the 
non-CDHP population.  
Examining by service categories revealed 
that the share of costs borne by the 
CDHP population on professional services 
and prescriptions was more than 30% of 
the total per capita spending on those 
services per year, on average (Exhibit 5). 
Professional services had the highest 
share of cost for the CDHP population 
(32% on average). In contrast, for the non
-CDHP population, the largest share of 
cost was for prescriptions (20% on aver-
age). The share of costs for both popula-
tions was lowest on inpatient admissions. 
The CDHP population paid 6% of the per 
capita inpatient spending out of pocket, 
compared to 5% for the non-CDHP popu-
lation. Overall, on all the service catego-
ries, the CDHP population had a share of 
cost higher than that of the non-CDHP 
population.  
Conclusion 
Across the study period, the CDHP popu-
lation had lower total per capita spend-
ing, as compared to that of the non-CDHP 
population. The CDHP population had, on 
average, annual per capita spending that 
Exhibit 5. Average Share of Costs, 
by Service Category (2010 - 2014) 
Service Category Non-CDHP CDHP 
All Services 14% 24% 
Inpatient Admissions 5% 6% 
Outpatient Services 13% 24% 
Professional Services 18% 32% 
Prescriptions 20% 31% 
Source: HCCI, 2016. Note: Share of cost is calculat-
ed as the 5-year per capita out-of-pocket spending 
average divided by the 5-year total per capita spend 
average, Tables 1 and 2 and Tables 9 and 10. 
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was $520 less than that of the non-CDHP 
population (Table 1). That pattern of com-
paratively higher total spending for the 
non-CDHP population was observed for 
all health service categories and nearly all 
demographic groups. Those differences in 
total per capita spending arose in part 
from differences in utilization across the 
populations. For all service and subservice 
categories, outside of brand prescriptions, 
the CDHP population used approximately 
10% fewer services as compared to use by 
the non-CDHP population each year 
(Table 4). For brand prescriptions, the 
CDHP population used more than 20% 
fewer filled days than did the non-CDHP 
population.  
Although the CDHP population generally 
had lower total per capita spending 
(excluding premiums) and utilization 
rates, as compared to the non-CDHP pop-
ulation, the opposite was true of out-of-
pocket spending. Over the study period, 
the CDHP population spent, on average, 
$343 more out of pocket per capita than 
did the non-CDHP population each year 
(Table 9). For the majority of the study 
period (2012–2014), the CDHP popula-
tion’s per capita out-of-pocket costs were 
more than 1.5 times higher than those for 
the non-CDHP population. The CDHP pop-
ulation’s per capita spending rates com-
bined with higher out-of-pocket costs 
resulted in the larger share of cost differ-
ences between the two populations. 
Though the non-CDHP population was 
responsible for roughly 14% of their medi-
cal costs on average, the CDHP population 
paid for 24% of their medical costs out-of-
pocket (Table 1 and Table 9). Overall, the 
CDHP population tended to have lower 
total per capita spending and utilization 
rates, but higher out-of-pocket spending 
in comparison to those of the non-CDHP 
population.  
 
Data and Methods 
This issue brief used an analytic dataset 
that consisted of population weighted 
and aggregated claims data for people 
younger than age 65 and covered by ESI 
for calendar years 2010 to 2014. The ana-
lytic dataset was derived from health care 
claims for 40 million Americans per year 
contributed by three national insurers. 
This was the same data set used by HCCI 
for the 2014 Health Care Cost and Utiliza-
tion Report. All data used for this study 
were de-identified and compliant with 
the Health Insurance Portability and Ac-
countability Act.  
An individual in the HCCI analytic dataset 
was flagged by their insurer as having 
been enrolled in a CDHP. This flag was 
assessed each year of the study period. 
This divided the total study population 
into two populations: CDHP members and 
non-CDHP members. A third group also 
identified in the study population was 
composed of individuals belonging to an 
unknown type of health plan. This group 
totaled approximately 2% of the total 
study population in each year studied. For 
this study, the individuals in the unknown 
group were added to the non-CDHP study 
population, ensuring that this study’s 
population is comparable to populations 
in other HCCI reports. Therefore, these 
two populations—individuals having a 
CDHP and individuals without a CDHP—
are similar but not methodologically iden-
tical.  
The trends for the two study populations 
were analyzed by per capita spending, 
utilization of health services, and out-of-
pocket spending. All trends presented 
here should be treated as population esti-
mates. 
For this study, HCCI did not seek to deter-
mine what role premiums, services cov-
ered, or specific aspects or changes in 
benefit designs played in the spending 
and utilization rates observed.  
Claims for 2013 and 2014 were adjusted 
using actuarial completion to account for 
claims incurred but not adjudicated. HCCI 
used these weighted and adjusted claims 
to calculate total and out-of-pocket ex-
penditures for 2010 through 2014. HCCI 
did not correct dollars for inflation; thus, 
all reported expenditures are in nominal 
dollars. For a more detailed description of 
the analytic dataset and methods used in 
this study, see 2014 Health Care Cost and 
Utilization Report and the corresponding 
methodology document, available on the 
HCCI Website. 
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Table 1. Per Capita Spending for CDHP and Non-CDHP Populations  
  2010 2011 2012 2013 2014 
CDHP Population           
Per Capita  $3,962  $4,124  $4,268  $4,399  $4,481  
Per Capita by Gender           
Men $3,462  $3,611  $3,712  $3,856  $3,939  
Women $4,450  $4,622  $4,807  $4,922  $5,005  
Per Capita by Age           
18 and Younger $2,157  $2,278  $2,346  $2,430  $2,500  
19-25 $2,299  $2,429  $2,579  $2,665  $2,778  
26-44 $3,485  $3,607  $3,795  $3,860  $3,883  
45-54 $5,127  $5,297  $5,526  $5,711  $5,859  
55-64 $7,712  $8,049  $8,139  $8,385  $8,590  
Non-CDHP Population            
Per Capita $4,401  $4,598  $4,765  $4,932  $5,140  
Per Capita by Gender           
Men $3,881  $4,080  $4,220  $4,375  $4,586  
Women $4,901  $5,095  $5,291  $5,474  $5,678  
Per Capita by Age           
18 and Younger $2,187  $2,374  $2,489  $2,617  $2,721  
19-25 $2,240  $2,426  $2,549  $2,651  $2,752  
26-44 $3,870  $4,016  $4,197  $4,323  $4,467  
45-54 $5,755  $5,993  $6,212  $6,412  $6,669  
55-64 $8,579  $8,863  $9,026  $9,320  $9,746  
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All per capita dollars from allowed amount. All figures rounded.  
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Table 2. Per Capita Spending for CDHP and Non-CDHP Populations, 
by Service Category  
  2010 2011 2012 2013 2014 
CDHP Population           
Inpatient $827  $852  $862  $894  $898  
     Acute Inpatient $814  $843  $853  $886  $890  
Outpatient $1,097  $1,162  $1,221  $1,279  $1,310  
     Visits $673  $720  $762  $801  $823  
     Other $424  $442  $459  $478  $488  
Professional Procedures $1,420  $1,469  $1,507  $1,535  $1,557  
Prescriptions $618  $641  $677  $690  $715  
     Brands $414  $439  $441  $448  $469  
     Generics $204  $202  $236  $243  $246  
Non-CDHP Population            
Inpatient $927  $968  $984  $1,012  $1,037  
     Acute Inpatient $908  $953  $970  $999  $1,024  
Outpatient $1,167  $1,241  $1,314  $1,369  $1,434  
     Visits $709  $756  $806  $843  $890  
     Other $458  $485  $508  $526  $544  
Professional Procedures $1,512  $1,576  $1,620  $1,674  $1,711  
Prescriptions $794  $812  $847  $877  $959  
     Brands $536  $560  $561  $578  $633  
     Generics $258  $251  $286  $300  $325  
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All per capita dollars from allowed amount. All figures rounded.  
Table 3. Per Capita Spending on Inpatient Admissions for CDHP and 
Non-CDHP Populations, by Detailed Service Category  
  2010 2011 2012 2013 2014 
CDHP Population           
     Hospice $2  $2  $2  $2  $1  
     Labor and Delivery $71  $77  $82  $86  $88  
     Medical $237  $253  $256  $267  $261  
     Mental Health and Substance Use $24  $28  $29  $33  $33  
     Newborns $47  $44  $47  $49  $50  
     Skilled Nursing Facility $5  $5  $5  $5  $6  
     Surgery $435  $441  $438  $451  $457  
     Ungroupable $6  $2  $2  $1  $1  
Non-CDHP Population            
     Hospice $2  $2  $2  $2  $2  
     Labor and Delivery $77  $82  $87  $92  $96  
     Medical $277  $298  $301  $304  $310  
     Mental Health and Substance Use $27  $33  $34  $35  $37  
     Newborns $41  $45  $47  $52  $55  
     Skilled Nursing Facility $7  $7  $7  $7  $7  
     Surgery $485  $494  $501  $515  $526  
     Ungroupable $11  $6  $5  $4  $3  
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All per capita dollars from allowed amount. All figures rounded.  
12 www.healthcostinstitute.org 
 
 
Table 4. Utilization per 1,000 Insureds for CDHP and Non-CDHP Pop-
ulations, by Service Category  
  2010 2011 2012 2013 2014 
CDHP Population           
Inpatient 55 53 52 51 49 
     Acute Inpatient 53 51 50 50 48 
Outpatient 2,643 2,680 2,689 2,680 2,629 
     Visits 291 296 299 301 296 
          Emergency Room Visits 152 156 164 165 166 
     Other 2,352 2,384 2,390 2,380 2,333 
Professional Procedures 14,709 14,964 15,175 15,106 14,905 
          Doctor's Visits 3,131 3,179 3,181 3,221 3,160 
Prescriptions - Filled Days 241,211 247,468 253,696 254,222 251,196 
     Brands 65,136 57,868 45,531 37,736 30,643 
     Generics 176,067 189,587 208,141 216,475 220,526 
Non-CDHP Population            
Inpatient 63 62 60 58 56 
     Acute Inpatient 60 59 57 56 55 
Outpatient 2,941 2,983 2,985 2,949 2,907 
     Visits 323 330 331 326 325 
          Emergency Room Visits 172 178 183 178 181 
     Other 2,617 2,653 2,654 2,623 2,583 
Professional Procedures 16,181 16,403 16,707 16,880 16,729 
          Doctor's Visits 3,386 3,434 3,421 3,496 3,441 
Prescriptions - Filled Days 283,990 284,569 286,571 289,122 291,248 
     Brands 81,193 71,839 57,416 48,873 41,894 
     Generics 202,768 212,697 229,101 240,203 249,280 
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All figures rounded.  
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Table 5. Utilization per 1,000 Insureds of Prescriptions for CDHP 
and Non-CDHP Populations, by Detailed Service Category  
  2010 2011 2012 2013 2014 
CDHP Population           
Brands – Filled Days 65,136 57,868 45,531 37,736 30,643 
     Anti-Infective Agents 1,371 1,321 1,186 1,156 1,092 
     Cardiovascular Drugs 19,057 16,924 11,398 8,779 6,397 
     Central Nervous System Agents 12,183 10,603 8,130 6,874 4,756 
     Eye, Ear, Nose, Throat Preparations 3,603 2,949 2,531 2,264 1,707 
     Gastrointestinal Drugs 2,949 2,535 2,378 2,144 1,627 
     Hormones and Synthetic Substitutes 13,632 13,853 10,455 9,557 8,704 
     Other Therapeutic Classes 7,796 5,397 4,108 3,420 3,153 
     Respiratory Drugs 2,967 2,780 4,002 2,521 2,395 
     Skin and Mucous Membrane Agents 1,580 1,504 1,344 1,021 812 
Generics – Filled Days 176,067 189,587 208,141 216,475 220,526 
     Anti-Infective Agents 10,004 10,363 10,553 10,313 10,008 
     Cardiovascular Drugs 44,312 48,302 54,950 56,929 58,585 
     Central Nervous System Agents 45,505 50,051 55,254 57,206 58,431 
     Eye, Ear, Nose, Throat Preparations 4,141 5,123 5,808 6,035 6,277 
     Gastrointestinal Drugs 5,955 7,079 7,895 8,290 8,505 
     Hormones and Synthetic Substitutes 32,683 34,896 37,072 39,022 40,543 
     Other Therapeutic Classes 28,794 28,853 30,163 30,153 29,526 
     Respiratory Drugs 663 779 2,112 3,975 4,101 
     Skin and Mucous Membrane Agents 4,010 4,141 4,335 4,553 4,549 
Non-CDHP Population            
Brands – Filled Days 81,193 71,839 57,416 48,873 41,894 
     Anti-Infective Agents 1,896 1,839 1,624 1,561 1,487 
     Cardiovascular Drugs 24,123 21,181 14,217 11,263 8,731 
     Central Nervous System Agents 15,255 13,342 10,582 9,264 6,752 
     Eye, Ear, Nose, Throat Preparations 4,218 3,523 3,135 2,893 2,421 
     Gastrointestinal Drugs 4,212 3,601 3,511 3,390 2,826 
     Hormones and Synthetic Substitutes 16,264 16,496 12,671 11,942 11,650 
     Other Therapeutic Classes 9,793 6,801 5,175 4,292 4,138 
     Respiratory Drugs 3,564 3,263 4,829 2,977 2,858 
     Skin and Mucous Membrane Agents 1,868 1,794 1,672 1,291 1,032 
Generics – Filled Days 202,768 212,697 229,101 240,203 249,280 
     Anti-Infective Agents 11,050 11,381 11,487 11,330 11,145 
     Cardiovascular Drugs 50,691 53,380 59,739 62,658 66,160 
     Central Nervous System Agents 54,343 58,507 63,141 65,420 67,788 
     Eye, Ear, Nose, Throat Preparations 4,477 5,384 6,033 6,307 6,666 
     Gastrointestinal Drugs 7,725 8,506 9,132 9,765 10,383 
     Hormones and Synthetic Substitutes 36,004 37,392 38,925 40,841 42,647 
     Other Therapeutic Classes 33,206 32,620 33,427 34,054 34,250 
     Respiratory Drugs 798 941 2,389 4,572 4,759 
     Skin and Mucous Membrane Agents 4,476 4,588 4,829 5,255 5,482 
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All figures rounded.  
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Table 6. Utilization per 1,000 Insureds for the CDHP Population, by 
Age & Service Category  
  2010 2011 2012 2013 2014 
CDHP Population           
Inpatient 55 53 52 51 49 
     18 and Younger 39 39 37 37 36 
     19-25 41 41 43 43 42 
          Men 19 22 23 23 24 
          Women 64 61 62 63 60 
     26-44 60 59 58 56 54 
     45-54 51 49 47 47 44 
     55-64 86 83 79 79 76 
Outpatient 2,643 2,680 2,689 2,680 2,629 
     18 and Younger 1,250 1,273 1,298 1,291 1,277 
     19-25 1,513 1,565 1,609 1,618 1,649 
          Men 1,014 1,069 1,100 1,106 1,163 
          Women 2,014 2,067 2,127 2,142 2,143 
     26-44 2,314 2,343 2,391 2,355 2,288 
     45-54 3,601 3,673 3,678 3,692 3,641 
     55-64 5,290 5,352 5,278 5,233 5,138 
Professional Procedures 14,709 14,964 15,175 15,106 14,905 
     18 and Younger 10,617 10,914 10,989 11,048 11,041 
     19-25 8,980 9,235 9,631 9,705 9,974 
          Men 5,540 5,854 6,260 6,414 6,825 
          Women 12,431 12,660 13,050 13,063 13,168 
     26-44 13,727 13,972 14,443 14,201 13,929 
     45-54 17,862 18,237 18,576 18,577 18,364 
     55-64 23,485 23,757 23,564 23,351 22,774 
Prescriptions - Filled Days 241,211 247,468 253,696 254,222 251,196 
     18 and Younger 67,660 68,605 69,958 69,256 66,645 
     19-25 118,254 118,654 123,579 127,058 128,386 
          Men 57,390 58,634 61,446 62,311 61,113 
          Women 181,646 181,173 187,398 193,091 195,863 
     26-44 184,621 186,054 191,062 191,155 188,401 
     45-54 352,948 360,247 368,517 371,371 375,011 
     55-64 596,996 607,289 607,098 601,047 602,070 
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All figures rounded.  
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Table 7. Utilization per 1,000 Insureds for the Non-CDHP Population, 
by Age & Service Category  
  2010 2011 2012 2013 2014 
Non-CDHP Population            
Inpatient 63 62 60 58 56 
     18 and Younger 40 41 41 41 42 
     19-25 43 45 45 43 41 
          Men 21 25 25 24 24 
          Women 65 66 65 63 59 
     26-44 68 67 65 62 61 
     45-54 62 61 58 53 51 
     55-64 102 100 94 90 87 
Outpatient 2,941 2,983 2,985 2,949 2,907 
     18 and Younger 1,332 1,365 1,385 1,371 1,361 
     19-25 1,450 1,534 1,569 1,574 1,561 
          Men 1,001 1,086 1,117 1,141 1,141 
          Women 1,890 1,980 2,023 2,015 1,989 
     26-44 2,509 2,524 2,548 2,506 2,474 
     45-54 3,973 4,025 4,019 3,972 3,910 
     55-64 5,917 5,994 5,889 5,818 5,670 
Professional Procedures 16,181 16,403 16,707 16,880 16,729 
     18 and Younger 10,940 11,343 11,543 11,786 11,747 
     19-25 8,734 9,124 9,505 9,749 9,818 
          Men 5,514 5,943 6,309 6,701 6,956 
          Women 11,892 12,288 12,708 12,854 12,734 
     26-44 15,398 15,598 16,024 16,127 15,954 
     45-54 19,878 20,107 20,485 20,731 20,515 
     55-64 25,784 25,831 25,908 26,070 25,625 
Prescriptions - Filled Days 283,990 284,569 286,571 289,122 291,248 
     18 and Younger 73,720 74,413 75,541 75,604 74,423 
     19-25 122,500 120,302 122,633 124,965 123,608 
          Men 61,742 61,654 63,473 63,984 62,421 
          Women 181,845 178,263 181,507 186,786 185,892 
     26-44 211,673 212,294 214,698 217,117 215,878 
     45-54 417,770 420,889 424,872 429,784 436,201 
     55-64 705,500 706,654 704,947 704,157 708,650 
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All figures rounded.  
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Table 8. Utilization per 1,000 Insureds for CDHP and Non-CDHP Pop-
ulations, by Gender & Service Category  
  2010 2011 2012 2013 2014 
CDHP Population           
Males           
     Inpatient 42 41 39 39 38 
     Outpatient 2,183 2,210 2,205 2,204 2,168 
     Professional Procedures 11,851 12,055 12,206 12,217 12,080 
     Prescriptions - Filled Days 201,256 207,167 212,607 212,405 209,209 
Females           
     Inpatient 67 66 64 63 61 
     Outpatient 3,091 3,137 3,159 3,140 3,075 
     Professional Procedures 17,498 17,791 18,052 17,893 17,641 
     Prescriptions - Filled Days 280,367 286,802 293,472 294,517 291,646 
Non-CDHP Population            
Males           
     Inpatient 49 48 47 45 44 
     Outpatient 2,456 2,498 2,493 2,467 2,429 
     Professional Procedures 13,083 13,297 13,582 13,810 13,681 
     Prescriptions - Filled Days 241,395 242,709 244,990 246,845 248,478 
Females           
     Inpatient 76 75 73 70 68 
     Outpatient 3,406 3,448 3,459 3,418 3,372 
     Professional Procedures 19,157 19,387 19,720 19,865 19,693 
     Prescriptions - Filled Days 324,819 324,724 326,567 330,084 332,735 
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All figures rounded.  
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Table 9. Out-of-Pocket Per Capita Spending for CDHP and Non-CDHP 
Populations  
  2010 2011 2012 2013 2014 
CDHP Population           
Per Capita  $953  $973  $1,058  $1,081  $1,083  
Per Capita by Gender           
Men $807  $824  $891  $913  $915  
Women $1,095  $1,117  $1,219  $1,243  $1,245  
Per Capita by Age           
18 and Younger $564  $589  $643  $660  $668  
19-25 $714  $726  $790  $798  $815  
26-44 $958  $982  $1,072  $1,088  $1,095  
45-54 $1,163  $1,180  $1,281  $1,314  $1,323  
55-64 $1,534  $1,535  $1,654  $1,693  $1,673  
Non-CDHP Population            
Per Capita $659  $681  $689  $699  $709  
Per Capita by Gender           
Men $560  $580  $586  $597  $607  
Women $754  $778  $789  $797  $808  
Per Capita by Age           
18 and Younger $349  $366  $374  $383  $394  
19-25 $407  $424  $434  $425  $431  
26-44 $626  $651  $669  $673  $692  
45-54 $842  $870  $876  $892  $905  
55-64 $1,152  $1,180  $1,167  $1,190  $1,179  
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All per capita dollars from allowed amount. All figures rounded.  
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Table 10. Out-of-Pocket Per Capita Spending for CDHP and Non-
CDHP Populations, by Service Category & Select Detailed Catego-
ries  
  2010 2011 2012 2013 2014 
CDHP Population           
Inpatient $50  $51  $52  $61  $60  
     Acute Inpatient $50  $51  $52  $60  $60  
Outpatient $250  $260  $288  $309  $324  
     Visits $146  $154  $172  $187  $198  
          Emergency Room Visits $73  $78  $93  $103  $113  
     Other $104  $106  $116  $121  $126  
Professional Procedures $443  $453  $491  $499  $510  
          Doctor's Visits $137  $141  $151  $160  $163  
Prescriptions $209  $208  $227  $213  $188  
     Brands $118  $114  $112  $100  $86  
     Generics $91  $94  $115  $113  $102  
Non-CDHP Population            
Inpatient $42  $44  $45  $48  $47  
     Acute Inpatient $41  $44  $45  $47  $47  
Outpatient $152  $164  $173  $180  $193  
     Visits $90  $97  $102  $107  $114  
          Emergency Room Visits $34  $38  $42  $44  $50  
     Other $62  $67  $71  $74  $79  
Professional Procedures $274  $288  $293  $302  $312  
          Doctor's Visits $88  $90  $90  $95  $95  
Prescriptions $190  $185  $177  $168  $158  
     Brands $99  $92  $78  $69  $61  
     Generics $91  $92  $100  $99  $97  
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All per capita dollars from allowed amount. All figures rounded.  
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Table 11. HCCI Study Population Characteristics by CDHP and Non-
CDHP Populations  
  2010 2011 2012 2013 2014 
Percent of Total Study Population with CDHP           
Insureds with CDHP  15% 18% 21% 25% 27% 
Population by Gender           
Men 7% 9% 10% 12% 13% 
Women 7% 9% 11% 13% 14% 
Population by Age           
18 and Younger 4% 5% 6% 7% 7% 
19-25 1% 2% 2% 2% 3% 
26-44 4% 5% 6% 7% 8% 
45-54 3% 4% 4% 5% 5% 
55-64 2% 3% 3% 4% 4% 
Percent of CDHP Population with CDHP           
Insureds with CDHP 100% 100% 100% 100% 100% 
Population by Gender           
Men 49% 49% 49% 49% 49% 
Women 51% 51% 51% 51% 51% 
Population by Age           
18 and Younger 28% 27% 27% 27% 27% 
19-25 9% 9% 10% 10% 10% 
26-44 28% 28% 29% 29% 29% 
45-54 21% 20% 20% 20% 20% 
55-64 14% 14% 14% 15% 14% 
Percent of Total Study Population with Non-CDHP         
Insureds with Non-CDHP 85% 82% 79% 75% 73% 
Per Capita by Gender           
Men 42% 40% 39% 37% 36% 
Women 44% 42% 40% 38% 37% 
Per Capita by Age           
18 and Younger 22% 21% 20% 19% 18% 
19-25 8% 8% 8% 8% 8% 
26-44 25% 23% 22% 21% 20% 
45-54 17% 16% 16% 15% 14% 
55-64 13% 13% 13% 12% 12% 
Percent of Non-CDHP Population with Non-CDHP         
Insureds with Non-CDHP 100% 100% 100% 100% 100% 
Per Capita by Gender           
Men 49% 49% 49% 49% 49% 
Women 51% 51% 51% 51% 51% 
Per Capita by Age           
18 and Younger 26% 26% 26% 25% 25% 
19-25 9% 10% 10% 11% 11% 
26-44 29% 28% 28% 28% 28% 
45-54 20% 20% 20% 20% 19% 
55-64 16% 16% 16% 16% 17% 
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All figures rounded.  
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Table 12. Percentage of Non-Utilizers within the CDHP and Non-
CDHP Populations, by Age 
  2010 2011 2012 2013 2014 
CDHP Population           
Total Non-Utilizers 24% 23% 22% 23% 25% 
Non-Utilizers by Age           
18 and Younger 20% 18% 18% 19% 20% 
19-25 38% 35% 35% 36% 38% 
26-44 28% 27% 26% 28% 30% 
45-54 21% 20% 19% 19% 21% 
55-64 16% 14% 15% 15% 17% 
Non-CDHP Population            
Total Non-Utilizers 26% 25% 25% 26% 28% 
Per Capita by Age           
18 and Younger 22% 21% 21% 21% 23% 
19-25 46% 43% 43% 44% 46% 
26-44 29% 28% 29% 30% 31% 
45-54 21% 20% 20% 21% 22% 
55-64 15% 15% 15% 15% 17% 
Source: HCCI, 2016      
Notes: All data weighted to reflect the national population ages 0-64 and covered by ESI. Data for 2013 and 2014 adjusted using actuarial completion. 
All figures rounded.  
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